UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarter Ended ~~December~~June 3130, ~~2023~~2024

☐ Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from to .

Commission file number: ~~333~~000-~~256498~~56447

REST EZ, INC.

(Name of Registrant in Its Charter)

Wyoming		82-4268982
(State or Other Jurisdiction of Incorporation or		(I.R.S. Employer Identification No.)
Organization)

1398 W. Mason Hollow Dr.
Riverton, UT 84065
(Address of Principal Executive Offices)

(801) 300-2542
(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
None		None		None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ ☒ Smaller reporting company ☒ Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~February~~June 2030, 2024, there were 2720,~~537~~000,~~033~~000 shares of the registrant’s common stock outstanding.

FORM 10-Q

TABLE OF CONTENTS

Note About Forward-Looking Statements
PART I	FINANCIAL INFORMATION
Item 1.	Financial Statements	4
	Balance Sheets as of December 31, 2023 (Unaudited) and March 31, 2023	4
	Balance Sheets as of June 30, 2024 (Unaudited) and March 31, 2023	4
	Statements of Operations for the three and nine months ended December 31, 2023 and 2022 (Unaudited)	5
	Statements of Operations for the three months ended June 30, 2024 and 2023 (Unaudited)	5
	Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended December 31, 2023 and 2022 (Unaudited)	6
	Statements of Changes in Stockholders’ Equity (Deficit) for the three months ended June 30, 2024 and 2023 (Unaudited)	6
	Statements of Cash Flows for the nine months ended December 31, 2023 and 2022 (Unaudited)	7
	Statements of Cash Flows for the three months ended June 30, 2024 and 2023 (Unaudited)	7
	Notes to Financial Statements (Unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1211
Item 4.	Controls and Procedures	1614
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	1715
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	1715
Item 3.	Defaults Upon Senior Securities	1715
Item 4.	Mine Safety Disclosures	1715
Item 5.	Other Information	1715
Item 6.	Exhibits	1715
	Signatures	1816

Table of Contents

NOTE ABOUT FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, among other things, statements regarding plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. Forward-looking statements may appear throughout this report, including without limitation, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements generally can be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this report and in our Form S-1/A, and in particular, the risks discussed under the caption “Risk Factors” in Item 1A of this report and in in our Form S-1/A, and those discussed in other documents we file with the Securities and Exchange Commission (“SEC”). Important factors that in our view could cause material adverse effects on our financial condition and results of operations include, but are not limited to, risks associated with service demands and acceptance, our ability to expand, changes in healthcare practices, changes in technology, economic conditions, the impact of competition and pricing, government regulation and approvals, impacts and disruptions caused by the COVID-19 pandemic and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. We undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

As used herein, the “Company,” “we,” “our,” and similar terms include Rest EZ, Inc. and its predecessors, unless the context indicates otherwise.

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

REST EZ, INC.

BALANCE SHEETS

	December 31,			March 31,
	June 30,			March 31,
	2023			2023
	2024			2024
	(unaudited)
ASSETS
Current assets
Cash	$	-		$	44-
Inventory		2,550			2,550
Accounts Receivable – Related Party		13,500			13,500
Total Current Assets		2,550			2,594
Inventory		-			-
Total Assets		2,550			2,594
Total Current Assets		13,500			13,500
LIABILITIES AND STOCKHOLDERS' EQUITY
Total Assets		13,500			13,500
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable		~~430~~463			96430
Income taxes payable		41,687			41,687
Loan from related party		8,188			~~131~~8,~~375~~188
Total current liabilities		50,~~305~~338			~~173~~50,~~158~~305
Stockholders' deficit
Stockholders’ equity
Common stock, $0.001 par value, 100,000,000 shares authorized, 23,020,033 and 20,000 shares issued and outstanding as of December 31, 2023 and March 31, 2023, respectively		23,020			20,000
Common stock, $0.001 par value, 100,000,000 shares authorized, 20,000,000 shares issued and outstanding as of June 30, 2024 and March 31, 2024		25,910			25,910
Additional paid-in capital		~~264~~258,~~901~~864			~~121~~258,~~589~~864
Accumulated deficit		(335,676	)		(312,153	)
Retained earnings		(321,612	)		(321,579	)
Total stockholders' deficit		(47,755	)		(170,564	)
Total stockholders’ equity		(36,838	)		(36,805	)
Total liabilities and stockholders' deficit	$	2,550		$	2,594
Total liabilities and stockholders’ equity	$	13,500		$	13,500

The accompanying notes are an integral part of the unaudited financial statements.

Table of Contents

REST EZ, INC.

STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the						~~For the~~
	Three Months Ended						~~Nine Months Ended~~
	December 31,						December 31,
	June 30,
	2023			2022			2023			2022
	2024			2023
Revenue	$	-		$	-		$	-		$	-
Cost of goods sold		-			-			-			-
Gross profit		-			-			-			-
Operating expenses:
General and administrative		~~1,020~~33			23,~~061~~710			~~17,691~~			~~11,179~~
Total operating expenses		~~1,020~~33			23,~~061~~710			~~17,691~~			~~11,179~~
Net operating loss		(~~1,020~~33	)		(23,~~061~~710	)		~~(17,691~~	)		~~(11,179~~	)
Other expense:
Interest expense		~~(164~~-	)		(2,~~586~~074	)		~~(5,832~~	)		~~(7,671~~	)
Total other expense		~~(164~~-	)		(2,~~586~~074	)		~~(5,832~~	)		~~(7,671~~	)
Loss before provision for income taxes		(~~1,184~~33	)		(45,~~647~~784	)		~~(23,523~~	)		~~(18,850~~	)
Provision for income taxes		-			-			-			-
Net loss	$	(~~1,184~~33	)	$	(45,~~647~~784	)	$	~~(23,523~~	)	$	~~(18,850~~	)
Net loss per share - basic	$	(0.00	)	$	(0.2300	)	$	~~(0.03~~	)	$	~~(0.94~~	)
Net loss per share - diluted	$	(0.00	)	$	(0.2300	)	$	~~(0.03~~	)	$	~~(0.94~~	)
Weighted average shares outstanding - basic		220,~~270~~000,~~003~~000			20,000,000			~~772,728~~			~~20,000~~
Weighted average shares outstanding - diluted		220,~~270~~000,~~003~~000			20,000,000			~~772,728~~			~~20,000~~

The accompanying notes are an integral part of the unaudited financial statements.

Table of Contents

REST EZ, INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

(UNAUDITED)

For the Three Months Ended ~~December~~June 3130, ~~2023~~2024 and ~~2022~~2023

										Total
					Additional					Stockholders'’
	Common Stock				Paid-In		Accumulated			Equity
	Shares		Amount		Capital		Deficit			(Deficit)
Balance, September 30, 2022		20,000	$	20	$	136,356	$	102,350		$	238,726
Balance, March 31, 2023		20,000,000	$	20,000	$	121,589	$	(312,153	)	$	(170,564	)
Imputed interest on related party loan		-		-		2,~~586~~074		-			2,~~586~~074
Net loss for the three months ended December 31, 2022		-		-				(4,647	)		(4,647	)
Net loss for the three months ended June 30, 2023		-		-		-		(5,784	)		(5,784	)
Balance, December 31, 2022		20,000	$	20	$	138,942	$	97,703		$	236,665
Balance, June 30, 2023		20,000,000	$	20,000	$	123,663	$	(317,937	)	$	(174,274	)
Balance, September 30, 2023		20,000	$	20	$	147,237	$	(334,492	)	$	(187,235	)
Balance, March 31, 2024		20,000,000	$	25,910	$	258,864	$	(321,579	)	$	(36,805	)
Common stock issued for conversion of loan payable		23,000,000		23,000		117,500					140,500
Imputed interest on related party loan		-		-		-		-
Common stock issued for rounding (reverse stock split)		33		-		-		-			-
Net loss for the three months ended June 30, 2024		-		-		-		(33	)		(33	)
Imputed interest on related party loan		-		-		164		-			164
Balance, June 30, 2024		20,000,000	$	25,910	$	258,864	$	(321,612	)	$	(36,838	)
Net loss for the three months ended December 31, 2023		-		-		-		(1,184	)		(1,184	)
Balance, December 31, 2023		23,020,033	$	23,020	$	264,901	$	(335,676	)	$	(47,755	)

~~For~~The accompanying ~~the~~notes ~~Nine~~are ~~Months~~an ~~Ended~~integral ~~December~~part ~~31,~~of ~~2023~~the ~~and~~unaudited ~~2022~~financial statements.

										Total
					Additional					Stockholders'
	Common Stock				Paid-In		Accumulated			Equity
	Shares		Amount		Capital		Deficit			(Deficit)
Balance, March 31, 2022		20,000	$	20	$	131,271	$	116,553		$	247,844
Imputed interest on related party loan		-		-		7,671		-			7,671
Net loss for the nine months ended December 31, 2022		-		-		-		(18,850	)		(18,850	)
Balance, December 31, 2022		20,000	$	20	$	138,942	$	97,703		$	236,665
Balance, March 31, 2023		20,000	$	20	$	141,569	$	(312,153	)	$	(170,564	)
Common stock issued for conversion of loan payable		23,000,000		23,000		117,500					140,500
Common stock issued for rounding (reverse stock split)		33		-		-		-			-
Imputed interest on related party loan		-		-		5,832		-			5,832
Net loss for the nine months ended December 31, 2023		-		-		-		(23,523	)		(23,523	)
Balance, December 31, 2023		23,020,033	$	23,020	$	264,901	$	(335,676	)	$	(47,755	)

~~The~~Table ~~accompanying notes are an integral part~~ of ~~the unaudited financial statements.~~Contents

6REST EZ, INC.

~~Table~~STATEMENTS OF ofCASH ~~Contents~~FLOWS

~~REST EZ, INC.~~(UNAUDITED)

STATEMENTS OF CASH FLOWS

	For the
	Three Months Ended
	June 30,
	2024			2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(33	)	$	(5,784	)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related party loan		-			2,074

Changes in assets and liabilities:
Accounts payable		33			(96	)
Net cash used in operating activities		-			(3,806	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party debt		-			3,840
Net cash provided by financing activities		-			3,840

Net decrease in cash and cash equivalents		-			34

Cash and cash equivalents at beginning of period		-			44

Cash and cash equivalents at end of period	$	-		$	78

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
None.

~~(UNAUDITED)~~The accompanying notes are an integral part of the unaudited financial statements.

	For the
	Nine Months Ended
	December 31,
	2023			2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(23,523	)	$	(18,850	)
Adjustments to reconcile net loss to net cash used in operating activities:
Imputed interest on related party loan		5,832			7,671
Changes in assets and liabilities:
Accounts payable		334			96
Net cash used in operating activities		(17,357	)		(11,083	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from related party debt		17,313			10,829
Net cash provided by financing activities		17,313			10,829
Net decrease in cash and cash equivalents		(44	)		(254	)
Cash and cash equivalents at beginning of period		44			431
Cash and cash equivalents at end of period	$	-		$	177
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Conversion of loan payable to common stock	$	140,500		$	-

~~The~~Table ~~accompanying notes are an integral part~~ of ~~the unaudited financial statements.~~Contents

7REST EZ, INC.

~~Table~~NOTES TO ofUNAUDITED ~~Contents~~FINANCIAL STATEMENTS

~~REST EZ~~June 30, ~~INC.~~2024

~~NOTES~~Note 1. TOGeneral ~~UNAUDITED~~Organization ~~FINANCIAL~~and ~~STATEMENTS~~Business

~~December~~Rest EZ, 31Inc. (the “Company”) was incorporated on October 17, ~~2023~~2016. The Company has passed through all stages of development to full operations from incorporation, at the present time the company is currently in full Production and Distribution to wholesalers and retailers as well as online at www.RestEz.net. Rest EZ Inc. has commenced its major operations of having one product a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider (Sport Energy) that manufactures liquid gels to various Companies, but has not distributed this product to anyone except Rest EZ Inc.

~~Note~~The Company’s 1.year-end ~~General~~is ~~Organization~~March ~~and Business~~31.

~~Rest EZ, Inc~~Note 2. ~~(the~~Summary ~~“Company”) was incorporated on October 17, 2016. The Company has passed through all stages~~ of ~~development~~Significant toAccounting full operations from incorporation, at the present time the company is currently in full Production and Distribution to wholesalers and retailers as well as online at www.RestEz.net. Rest EZ Inc. has commenced its major operations of having one product a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider (Sport Energy) that manufactures liquid gels to various Companies, but has not distributed this product to anyone except Rest EZ Inc.Policies

~~The~~Basis of ~~Company’s year-end is March 31.~~Presentation

~~Note~~The financial 2statements have been prepared in accordance with United States generally accepted accounting principles and reflect all adjustments which, in the opinion of management, are necessary for a fair presentation. ~~Summary~~All such adjustments are of ~~Significant~~a ~~Accounting~~normal ~~Policies~~recurring nature. Interim results are not necessarily indicative of results for a full year. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the Company’s financial statements for the year ended March 31, 2024, contained in the Company’s annual report on 10-K/A filed with the SEC on February 13, 2025.

~~Basis~~ Use of ~~Presentation~~Estimates

The preparation of financial statements ~~have been prepared~~ in ~~accordance~~conformity with ~~United~~GAAP ~~States~~requires ~~generally~~management ~~accepted~~to ~~accounting~~make ~~principles~~estimates and ~~reflect~~assumptions ~~all~~that ~~adjustments~~affect ~~which, in~~ the ~~opinion~~reported amounts of ~~management,~~assets ~~are~~and ~~necessary~~liabilities, ~~for~~revenue aand ~~fair~~expenses, ~~presentation.~~and ~~All~~disclosure ~~such adjustments are~~ of acontingent ~~normal~~liabilities ~~recurring~~in ~~nature.~~advance ~~Interim results are not necessarily indicative~~ of ~~results~~all ~~for~~conditions abeing met ~~full~~at ~~year.~~the ~~The~~date ~~information~~of ~~included in this Quarterly Report on Form 10-Q should be read in conjunction with~~ the ~~Company’s~~ financial statements. ~~for~~Actual ~~the~~results ~~year~~could ~~ended~~differ ~~March~~from ~~31,~~those ~~2023, contained in the Company’s annual report on 10-K/A filed with the SEC on September 13, 2023~~estimates.

OnFair Value ~~September 26, 2023, the Company’s board~~ of ~~directors~~Financial approved a reverse stock split in the ration of 1 for 1000. There were 20,000,000 shares of the Company’s common stock outstanding immediately before the reverse stock split, and 20,000 shares of common stock outstanding immediately after the reverse stock split, a decrease of 19,980,000 shares.Instruments

~~Use~~The Company’s balance sheet includes certain financial instruments. The carrying amounts of ~~Estimates~~current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization.

~~The~~FASB Accounting ~~preparation~~Standards ofCodification ~~financial~~(ASC) ~~statements~~820 inFair ~~conformity~~Value ~~with~~Measurements ~~GAAP~~and ~~requires~~Disclosures ~~management~~(ASC 820) defines fair value as the exchange price that would be received for an asset or paid to ~~make~~transfer ~~estimates~~a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions ~~that~~about ~~affect~~market participant assumptions developed based on the ~~reported~~best information ~~amounts~~available in the circumstances (unobservable inputs). The fair value hierarchy consists of ~~assets~~three ~~and~~broad ~~liabilities~~levels, ~~revenue~~which ~~and~~gives the ~~expenses,~~highest ~~and~~priority ~~disclosure~~to ofunadjusted ~~contingent~~quoted ~~liabilities~~prices in ~~advance~~active ofmarkets ~~all~~for ~~conditions~~identical ~~being~~assets ~~met~~or atliabilities ~~the~~(Level ~~date~~1) ofand the ~~financial~~lowest ~~statements~~priority to unobservable inputs (Level 3). ~~Actual~~The ~~results~~three ~~could~~levels ~~differ~~of ~~from~~the ~~those~~fair ~~estimates.~~value hierarchy are described below:

Fair Value of Financial Instruments

Level 1 -	Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

Level 2 -	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 -	Inputs that are both significant to the fair value measurement and unobservable.

The adoption of this standard did not have a material effect on the Company’s ~~balance~~financial ~~sheet~~statements ~~includes~~as ~~certain~~reflected ~~financial instruments~~herein. The carrying amounts of ~~current~~cash ~~assets~~ and ~~current~~accrued ~~liabilities~~expenses ~~approximate~~reported ~~their~~on the balance sheet are estimated by management to approximate fair value ~~because~~primarily ofdue to the ~~relatively~~ short-term ~~period~~nature ~~between~~of the ~~origination~~instruments. ofThe ~~these~~Company ~~instruments~~had ~~and~~no ~~their~~items ~~expected~~that ~~realization~~required fair value measurement on a recurring basis.

FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures (ASC 820) defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:8

Level 1 -	Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
Level 2 -	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 -	Inputs that are both significant to the fair value measurement and unobservable.

Table of Contents

8Revenue Recognition

~~Table~~The Company recognizes revenue from product sales upon product delivery. All of ~~Contents~~our products are shipped through a third-party fulfillment center to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues. Deferred revenue recorded on the balance sheet represents payments received by the Company in advance of the product being delivered.

~~The~~We adopted ~~adoption~~ASC ofTopic ~~this~~606, ~~standard~~“Revenue ~~did~~from ~~not~~Contracts ~~have~~with aCustomers”, ~~material~~and ~~effect~~all onrelated ~~the~~interpretations ~~Company’s~~for ~~financial~~recognition ~~statements~~of asour ~~reflected herein~~revenue. Under ~~The~~ASC ~~carrying~~606, ~~amounts~~the Company recognizes revenue from the commercial sales of ~~cash~~products ~~and~~by ~~accrued~~applying ~~expenses~~the ~~reported~~following onsteps: (1) identifying the ~~balance~~contract ~~sheet~~with ~~are~~a ~~estimated~~customer; by(2) ~~management~~identifying tothe ~~approximate~~performance ~~fair~~obligations ~~value~~in ~~primarily~~the ~~due~~contract; to(3) determining the ~~short-term~~transaction ~~nature~~price; of(4) allocating the ~~instruments.~~transaction ~~The~~price ~~Company~~to ~~had~~each noperformance ~~items~~obligation ~~that~~in ~~required~~the ~~fair~~contract; ~~value~~and ~~measurement~~(5) onrecognizing arevenue ~~recurring~~when ~~basis~~each performance obligation is satisfied.

~~Revenue~~There was ~~Recognition~~no revenue during the three months ended June 30, 2024 or 2023.

~~The Company recognizes revenue from product sales upon product delivery. All of our products are shipped through a third-party fulfillment center to the customer~~ Cash and ~~the~~Cash customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues. Deferred revenue recorded on the balance sheet represents payments received by the Company in advance of the product being delivered.Equivalents

WeAll cash ~~adopted~~is ~~ASC~~maintained ~~Topic~~with ~~606,~~a ~~“Revenue~~major ~~from~~financial ~~Contracts~~institution ~~with~~in ~~Customers”,~~the ~~and~~United ~~all~~States. ~~related~~Deposits ~~interpretations~~with ~~for~~this ~~recognition~~bank may occasionally exceed the amount of ~~our~~insurance ~~revenue~~provided on such deposits. ~~Under~~For ~~ASC~~the ~~606,~~purpose of the ~~Company~~financial ~~recognizes~~statements, ~~revenue~~cash ~~from~~includes ~~the~~cash ~~commercial~~in ~~sales~~banks. Cash was $0 and $0 as of ~~products~~June by30, ~~applying~~2024 ~~the~~and ~~following~~March ~~steps:~~31, ~~(1)~~2024, ~~identifying~~respectively. ~~the~~There ~~contract~~were ~~with~~no acash ~~customer;~~equivalents ~~(2)~~as ~~identifying~~of ~~the~~June ~~performance~~30, ~~obligations~~2024 inand ~~the~~March ~~contract;~~31, ~~(3)~~2024. ~~determining~~The ~~the~~Federal Deposit ~~transaction~~Insurance ~~price;~~Corporation (4“FDIC”) ~~allocating~~insures ~~the~~these ~~transaction~~balances ~~price~~up to ~~each~~$250,000. ~~performance~~At ~~obligation~~June in30, ~~the~~2024 ~~contract;~~ and ~~(5)~~March ~~recognizing~~31, ~~revenue~~2024, ~~when~~cash ~~each~~in excess ~~performance~~of ~~obligation~~the isinsured ~~satisfied~~amount was $0.

~~Cash and Cash Equivalents~~Inventories

~~All~~Inventories are ~~cash~~stated isat ~~maintained with a major financial institution in~~ the ~~United~~lower ~~States. Deposits with this bank may occasionally exceed the amount~~ of ~~insurance~~cost ~~provided~~or onnet ~~such~~realizable ~~deposits.~~value, ~~For~~using the ~~purpose of the financial statements~~first-in, ~~cash~~first-out ~~includes~~method. ~~cash~~The inCompany ~~banks.~~reviews ~~Cash~~its ~~was~~inventory $0for obsolescence and ~~$44~~any asinventory ofidentified ~~December~~as ~~31,~~obsolete ~~2023~~is ~~and~~reserved ~~March~~or ~~31,~~written ~~2023, respectively~~off. ~~There~~The ~~were~~Company’s nodetermination ~~cash equivalents as~~ of ~~December~~obsolescence ~~31,~~is based ~~2023~~on ~~and~~assumptions ~~March~~about ~~31,~~the ~~2023.~~demand ~~The~~for ~~Federal~~its ~~Deposit~~products, ~~Insurance~~product ~~Corporation~~expiration ~~(“FDIC”)~~dates, ~~insures~~estimated ~~these~~future ~~balances~~sales, upand tomanagement’s ~~$250,000~~future plans.

~~Inventories~~Income Taxes

~~Inventories~~The Company accounts for income taxes under ASC 740 Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are ~~stated~~recognized atfor the ~~lower~~future tax consequences attributable to differences between the financial statements carrying amounts of ~~cost~~existing orassets ~~net~~and ~~realizable~~liabilities ~~value,~~and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the ~~first-~~years in, ~~first-out~~which ~~method.~~those ~~The~~temporary ~~Company~~differences ~~reviews~~are ~~its~~expected ~~inventory~~to ~~for~~be ~~obsolescence~~recovered or settled. The effect on deferred tax assets and ~~any~~liabilities ~~inventory~~of ~~identified~~a aschange ~~obsolete~~in tax rates is ~~reserved~~recognized orin ~~written~~income ~~off~~in the period the enactment occurs. A ~~The~~valuation ~~Company’s~~allowance ~~determination~~is ofprovided ~~obsolescence~~for certain deferred tax assets if it is ~~based~~more onlikely ~~assumptions~~than ~~about~~not that the ~~demand~~Company ~~for~~will ~~its~~not ~~products,~~realize ~~product~~tax assets ~~expiration~~through ~~dates,~~future ~~estimated~~operations. ~~future~~No ~~sales~~deferred tax assets or liabilities were recognized as of June 30, 2024 and ~~management’s~~March ~~future~~31, ~~plans~~2024.

~~Income~~Commitments and ~~Taxes~~Contingencies

The Company ~~accounts~~follows ~~for~~subtopic ~~income~~450-20 ~~taxes~~of ~~under ASC 740 Income Taxes. Under~~ the ~~asset~~FASB ~~and~~Accounting ~~liability~~Standards ~~method~~Codification ofto ~~ASC~~report ~~740,~~accounting ~~deferred~~for ~~tax~~contingencies. ~~assets~~Certain ~~and~~conditions may ~~liabilities~~exist ~~are~~as ~~recognized~~of ~~for~~ the ~~future~~date ~~tax consequences attributable to differences between~~ the financial statements ~~carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities~~ are ~~measured~~issued, ~~using~~which ~~enacted~~may ~~tax~~result ~~rates~~in ~~expected~~a toloss ~~apply~~ to ~~taxable income in~~ the ~~years~~Company, inbut which ~~those~~will ~~temporary~~only ~~differences are expected to~~ be ~~recovered~~resolved when one or ~~settled.~~more ~~The~~future ~~effect~~events onoccur ~~deferred~~or ~~tax~~fail ~~assets~~to ~~and liabilities of a change in tax rates is recognized in income in the period the enactment occurs~~occur. AThe ~~valuation~~Company ~~allowance~~assesses issuch ~~provided~~contingent ~~for~~liabilities, ~~certain~~and ~~deferred~~such ~~tax~~assessment ~~assets~~inherently involves ifan itexercise isof ~~more likely than not that the Company will not realize tax assets through future operations~~judgment. NoThere ~~deferred~~are ~~tax~~no ~~assets~~known commitments or ~~liabilities~~contingencies ~~were recognized~~ as of ~~December~~June 3130, ~~2023~~2024 and March 31, ~~2023~~2024.

~~Commitments~~Recently Issued ~~and~~Accounting ~~Contingencies~~Pronouncements

~~The~~From time ~~Company~~to ~~follows~~time, ~~subtopic~~new ~~450-20~~accounting ofpronouncements are issued by the ~~FASB~~Financial Accounting ~~Standards~~Standard ~~Codification~~Board to(“FASB”) ~~report~~or ~~accounting~~other ~~for~~standard setting ~~contingencies.~~bodies ~~Certain~~that ~~conditions~~the ~~may~~Company ~~exist~~adopts as of the ~~date~~specified ~~the~~effective ~~financial~~date. ~~statements~~Unless ~~are~~otherwise ~~issued~~discussed, ~~which~~the ~~may~~Company ~~result~~does innot abelieve ~~loss to~~ that the ~~Company,~~impact ~~but~~of ~~which~~recently ~~will~~issued ~~only~~standards bethat ~~resolved~~are ~~when~~not ~~one~~yet oreffective ~~more~~will ~~future~~have ~~events~~a ~~occur~~material orimpact ~~fail~~on tothe ~~occur. The~~ Company’s ~~assesses~~financial ~~such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments~~ position or ~~contingencies~~results as of ~~December~~operations ~~31,~~upon ~~2023 and March 31, 2023~~adoption.

~~Recently~~There are ~~Issued~~various ~~Accounting~~other ~~Pronouncements~~updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on our consolidated financial position, results of operations or cash flows.

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption.9

9Table of Contents

~~Table~~Note 3. ofGoing ~~Contents~~Concern

~~There~~The accompanying ~~are~~financial ~~various~~statements ~~other~~have ~~updates~~been ~~recently~~prepared ~~issued~~assuming that the Company will continue as a going concern. For the three months ended June 30, ~~most~~2024, the Company had a net loss of ~~which~~$33. ~~represented~~As ~~technical~~of ~~corrections~~June to30, 2024, the ~~accounting~~Company ~~literature~~had ora ~~application~~net toworking ~~specific~~capital ~~industries~~deficit of $36,838 and ~~are~~an accumulated deficit of $321,612. The Company has begun to recognize revenue, but without additional capital, the Company may not be ~~expected~~able to aremain ~~have~~in business. The continuation of the Company as a ~~material~~going ~~impact~~concern onis ~~our~~dependent ~~consolidated~~upon ~~financial~~(i) ~~position~~its ability to identify future investment opportunities, ~~results~~(ii) ofits ~~operations~~ability to obtain any necessary debt and/or ~~cash~~equity ~~flows~~financing, which may include loans from related parties, and (iii) its ability to generate profits from the Company’s future operations.

~~Note~~These factors 3raise a substantial doubt about the Company’s ability to continue as a going concern. ~~Going~~The ~~Concern~~accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

~~The~~Achievement of ~~accompanying financial statements have been prepared assuming that~~ the ~~Company~~Rest ~~will~~EZ, ~~continue as a going concern~~Inc.’s ~~For~~business ~~the~~objective ~~nine~~is ~~months~~basically ~~ended~~dependent ~~December~~upon ~~31,~~the ~~2023~~judgment, ~~the~~skill ~~Company~~and ~~had~~knowledge ~~a net loss~~ of ~~$23,523. As of December 31, 2023,~~ the Company’s management. ~~had a net working capital deficit of $47,755 and an accumulated deficit of $335,676~~Mr. ~~The~~Sosa ~~Company~~is ~~has~~currently ~~begun to recognize revenue, but without additional capital,~~ the Company’s ~~may~~sole ~~not~~executive beofficer ~~able~~and ~~to remain in business~~director. ~~The~~There ~~continuation~~can ofbe ~~the~~no ~~Company~~assurance asthat a ~~going~~suitable replacement ~~concern~~could isbe ~~dependent~~found ~~upon~~for ~~(i)~~our ~~its~~sole ~~ability~~executive toofficer ~~identify~~and ~~future~~director ~~investment~~upon ~~opportunities,~~his ~~(ii) its ability to obtain any necessary debt and/or equity financing~~retirement, ~~which may include loans from related parties~~resignation, ~~and~~inability ~~(iii) its ability~~ to ~~generate~~act ~~profits~~on ~~from~~our ~~the~~behalf, or ~~Company’s future operations~~death.

~~These factors raise a substantial doubt about the Company’s ability to continue as a going concern~~Note 4. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.Inventory

~~Achievement~~Inventory consists of ~~the~~one ~~Rest EZ~~product, ~~Inc.’s~~a ~~business~~liquid ~~objective~~gel iscapsule ~~basically~~named ~~dependent~~Rest ~~upon~~EZ ~~the~~Sleep ~~judgment~~Aid Supplement, ~~skill~~manufactured ~~and~~by ~~knowledge~~an ofunaffiliated ~~the~~outside ~~Company’s management~~provider. ~~Mr.~~At June ~~Sosa~~30, is2024 ~~currently the Company’s sole executive officer~~ and ~~director.~~March ~~There can be no assurance that a suitable replacement could be found for our sole executive officer and director upon his retirement~~31, ~~resignation~~2024, ~~inability~~inventory toconsisted ~~act~~of onthe ~~our behalf, or death.~~following:

Note 4. Inventory

		June 30, 2024				March 31, 2024
Finished Goods Inventory		$	0			$	0

~~Inventory consists of one product, a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider~~Note 5. AtRelated ~~December~~Party ~~31, 2023 and March 31, 2023, inventory consisted of the following:~~Transactions

		December 31, 2023				March 31, 2023
Finished Goods Inventory		$	2,550			$	2,550

As of June 30, 2024 and March 31, 2024, Brandon Sosa, President and sole stockholder of the Company, had loaned the Company the amount of $8,188 and $8,188, respectively, for operating capital. During the three months ended June 30, 2024 and 2023, the Company charged to operations the amount of $0 and $2,074, respectively, as imputed interest on these loans.

~~Note~~The Company 5uses a corporate office located at: 1398 W. ~~Related~~Mason ~~Party~~Hollow ~~Transactions~~Drive, Riverton, Utah 84065. This facility is being provided to the Company free of charge by the Company’s CEO.

AsNote 6. ~~of March 31, 2023, Brandon Sosa, the Company~~Stockholders’s CEO, had loaned the Company the amount of $131,375, for operating capital. During the three and nine months ended December 31, 2023, Mr. Sosa loaned the Company an additional $473 and $17,313, respectively. On December 22, 2023, $140,500 of this amount was converted to 23,000,000 shares of common stock at a price of $0.006 per share. During the three and nine months ended December 31, 2023, the Company charged to operations the amount of $164 and $5,832, respectively, as imputed interest on these loans. During the three and nine months ended December 31, 2022, the Company charged to operations the amount of $2,586 and $7,671, respectively, as imputed interest on these loans.Equity

The Company ~~uses~~has a100,000,000 ~~corporate~~authorized ~~office~~shares ~~located~~of ~~at:~~common ~~1398~~stock Wwith $0.001 ~~Mason~~par ~~Hollow~~value. ~~Drive,~~As ~~Riverton,~~of ~~Utah~~June ~~84065.~~30, ~~This~~2024 ~~facility~~and isMarch ~~being~~31, ~~provided~~2024, tothere ~~the~~were ~~Company~~20,000,000 shares ~~free~~ of ~~charge~~common bystock ~~the Company’s CEO~~outstanding.

~~Note~~During 6.the ~~Stockholders~~three months ended June 30, 2024 and 2023, the Company charged the amounts of $0 and $2,074 respectively, to additional paid-in capital pursuant to a loan from the Company’s President. ~~Equity~~See note 5.

~~The Company has 100,000,000 authorized shares of common stock with $0~~Note 7.~~001~~ ~~par~~Income value. On September 26, 2023, the Company’s board of directors approved a reverse stock split in the ratio of 1 for 1000. There were 20,000,000 shares of the Company’s common stock outstanding immediately before the reverse stock split, and 20,000 shares of common stock outstanding immediately after the reverse stock split, a decrease of 19,980,000 shares. The Company issued 33 shares of common stock due to rounding pursuant to the reverse stock split.Taxes

OnThere is ~~December~~no ~~22,~~current ~~2023,~~or ~~the~~deferred ~~Company~~income ~~issued~~tax ~~15,000,000~~expense ~~shares~~or ofbenefit ~~common~~for ~~stock~~the toperiod ~~its~~ended ~~CEO~~June ~~for~~30, ~~conversion of a loan~~2024.

OnThe Company ~~December~~has ~~22,~~not ~~2023,~~recognized an income tax expense or benefit for the ~~Company~~period ~~issued~~based ~~8,000,000~~on ~~shares~~uncertainties ofconcerning ~~common~~its ~~stock~~ability to ~~designees~~generate taxable ofincome ~~its~~in ~~CEO~~future periods. The tax expense for ~~conversion~~the ofcurrent period presented is offset by a ~~loan~~valuation allowance (100%) established against deferred tax assets arising from operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not.

As of ~~December~~June 3130, ~~2023~~2024 and March 31, ~~2023~~2024, ~~there~~the ~~were~~Company ~~23,020,033~~has ~~and~~recorded ~~20,000~~a ~~shares~~liability offor ~~common~~income ~~stock~~taxes ~~outstanding,~~payable ~~respectively~~in the amount of $41,687.

10Note 8. Subsequent Events

~~Table~~The Company ofhas ~~Contents~~evaluated events occurring subsequent to June 30, 2024 through the date these financial statements were issued and noted no items requiring disclosure.

During the three and nine months ended December 31, 2023, the Company charged the amounts of $164 and $5,832, respectively, to additional paid-in capital pursuant to a loan from the Company’s President. During the three and nine months ended December 31, 2022, the Company charged the amounts of $2,586 and $7,671, respectively, to additional paid-in capital pursuant to a loan from the Company’s President. See note 5.10

~~Note~~Table 7.of ~~Income Taxes~~Contents

~~There~~ITEM 2. isMANAGEMENT’S noDISCUSSION ~~current~~AND orANALYSIS ~~deferred~~OF ~~income~~FINANCIAL ~~tax~~CONDITION ~~expense~~AND orRESULTS ~~benefit~~OF ~~for the period ended December 31, 2023.~~OPERATIONS

~~The~~Forward Looking Company has not recognized an income tax expense or benefit for the period based on uncertainties concerning its ability to generate taxable income in future periods. The tax expense for the current period presented is offset by a valuation allowance (100%) established against deferred tax assets arising from operating losses and other temporary differences, the realization of which could not be considered more likely than not. In future periods, tax benefits and related deferred tax assets will be recognized when management considers realization of such amounts to be more likely than not.Statements

AsThe following ofdiscussion ~~December~~should ~~31,~~be ~~2023~~read ~~and~~in ~~March~~conjunction ~~31,~~with ~~2023,~~ the ~~Company~~consolidated ~~has~~financial ~~recorded~~statements aand ~~liability for income taxes payable in~~ the ~~amount~~related ofnotes ~~$41~~thereto,~~687.~~ ~~The~~as ~~Company~~well as isall ~~currently~~other ~~analyzing~~related ~~our~~notes, ~~net~~and ~~operating~~financial ~~losses~~ and ~~believes~~operational ~~that~~references, ~~they~~appearing ~~will~~elsewhere bein ~~sufficient to offset all or a significant portion of~~ this ~~liability~~document.

~~Note~~Certain information 8contained in this discussion and elsewhere in this report may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbor created by that act. ~~Subsequent~~The ~~Events~~safe harbor created by the Private Securities Litigation Reform Act will not apply to certain “forward looking statements” because we issued “penny stock” (as defined in Section 3(a)(51) of the Securities Exchange Act of 1934 and Rule 3(a)(51-1) under the Exchange Act) during the three year period preceding the date(s) on which those forward looking statements were first made, except to the extent otherwise specifically provided by rule, regulation or order of the Securities and Exchange Commission. We caution readers that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking statements which may be deemed to have been made in this Report or which are otherwise made by or on our behalf. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “expect”, “believe”, “explore”, “consider”, “anticipate”, “intend”, “could”, “estimate”, “plan”, “propose” or “continue” or the negative variations of those words or comparable terminology are intended to identify forward-looking statements. Factors that may affect our results include, but are not limited to, the risks and uncertainties associated with:

On● ~~January~~Our 14ability to raise capital necessary to sustain our anticipated operations and implement our business plan, ~~2024~~● Our ability to implement our business plan, ~~the~~● ~~Company~~Our ~~entered~~ability ~~into~~to ~~two~~generate ~~Convertible~~sufficient ~~Note~~cash ~~Agreements~~to ~~for~~pay anour ~~aggregate~~lenders ofand $3other creditors,~~200.~~ If● ~~not~~Our ~~paid~~ability ~~within~~to 2employ ~~business~~and ~~days~~retain qualified management and employees, ● Our dependence on the ~~notes~~efforts and abilities of our current employees and executive officers, ● Changes in government regulations that are ~~convertible~~applicable ~~into~~to ~~common~~our ~~stock~~current ator aanticipated ~~conversion~~business, ~~price~~● ofChanges ~~$.002~~in the demand for anour ~~aggregate~~services and different food trends, ● The degree and nature of 1our competition,~~867~~ ● The lack of diversification of our business plan,~~000.~~ ~~Per~~● ~~the~~The ~~terms~~general volatility of the ~~agreements,~~capital markets and the ~~notes~~establishment ~~were~~of ~~converted~~a ~~into~~market for our shares, and ● Disruption in the economic and financial conditions primarily from the impact of ~~common~~past ~~stock~~terrorist onattacks ~~February~~in 15the United States, ~~2024~~threats of future attacks, police and military activities overseas and other disruptive worldwide political and economic events, health pandemics and environmental weather conditions.

OnWe are ~~February~~also 9,subject ~~2024,~~to ~~the~~other ~~Company~~risks ~~entered~~detailed ~~into~~from ~~two~~time ~~Convertible~~to ~~Note~~time ~~Agreements~~in ~~for~~our another ~~aggregate~~filings with the SEC and elsewhere in this report. Any one or more of $5these uncertainties,~~300.~~ Ifrisks ~~not~~and ~~paid~~other ~~within~~influences 1could ~~business~~materially ~~day,~~affect ~~the~~our ~~notes~~results ~~are~~of ~~convertible~~operations ~~into~~and ~~common~~whether ~~stock~~forward-looking statements atmade aby ~~conversion~~us ~~price~~ultimately ofprove ~~$.002~~to ~~for~~be anaccurate. ~~aggregate~~Our ofactual 2results,~~650,000.~~ ~~Per~~performance ~~the~~and ~~terms~~achievements ofcould ~~the~~differ ~~agreements,~~materially ~~the~~from those ~~notes~~expressed ~~were~~or ~~converted~~implied ~~into~~in ~~shares~~these offorward-looking ~~common~~statements. ~~stock~~We onundertake ~~February~~no 15obligation to publicly update or revise any forward-looking statements, ~~2024~~whether from new information, future events or otherwise.

~~On January 17, 2024, the Company sold its remaining inventory of 533 bottles of Rest EZ Sleep Aid at $39.99 per bottle, for gross sales of $21,315.~~11

~~The~~Table ~~Company~~of ~~has evaluated events occurring subsequent to December 31, 2023 through the date these financial statements were issued and noted no additional items requiring disclosure.~~Contents

11Critical Accounting Policy and Estimates

~~Table~~Use of Estimates in the Preparation of ~~Contents~~Financial Statements

~~ITEM~~The preparation 2of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. ~~MANAGEMENT’S~~These ~~DISCUSSION~~estimates ~~AND~~include ~~ANALYSIS~~certain OFassumptions ~~FINANCIAL~~related to ~~CONDITION~~doubtful ~~AND~~accounts ~~RESULTS~~receivable, OFstock-based ~~OPERATIONS~~services, valuation of financial instruments, operating right of use assets and liabilities, and income taxes. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and concentration of credit risk. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Accounts subject to estimate and judgements are accounts receivable reserves, income taxes, intangible assets, contingent liabilities, and equity-based instruments. Actual results may differ from these estimates under different assumptions or conditions. We believe our estimates have not been materially inaccurate in past years, and our assumptions are not likely to change in the foreseeable future.

~~Forward~~Fair Value ~~Looking~~of ~~Statements~~Financial Instruments

The Company ~~following~~measures ~~discussion~~its ~~should~~financial beassets ~~read~~and liabilities in ~~conjunction~~accordance with accounting principles generally accepted in the ~~consolidated~~United ~~financial~~States of ~~statements~~America. ~~and~~The estimated fair values approximate their carrying value because of the ~~related~~short-term ~~notes~~maturity ~~thereto,~~of asthese ~~well~~instruments asor ~~all~~the stated ~~other~~interest ~~related~~rates ~~notes,~~are ~~and~~indicative ~~financial~~of ~~and~~market ~~operational~~interest ~~references,~~rates. ~~appearing~~These ~~elsewhere~~fair invalues ~~this~~have ~~document~~historically varied due to the market price of the Company’s stock at the date of valuation.

Certain information contained in this discussion and elsewhere in this report may include “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and is subject to the safe harbor created by that act. The safe harbor created by the Private Securities Litigation Reform Act will not apply to certain “forward looking statements” because we issued “penny stock” (as defined in Section 3(a)(51) of the Securities Exchange Act of 1934 and Rule 3(a)(51-1) under the Exchange Act) during the three year period preceding the date(s) on which those forward looking statements were first made, except to the extent otherwise specifically provided by rule, regulation or order of the Securities and Exchange Commission. We caution readers that certain important factors may affect our actual results and could cause such results to differ materially from any forward-looking statements which may be deemed to have been made in this Report or which are otherwise made by or on our behalf. For this purpose, any statements contained in this report that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “expect”, “believe”, “explore”, “consider”, “anticipate”, “intend”, “could”, “estimate”, “plan”, “propose” or “continue” or the negative variations of those words or comparable terminology are intended to identify forward-looking statements. Factors that may affect our results include, but are not limited to, the risks and uncertainties associated with:Income Taxes

●The Company ~~Our~~uses ~~ability~~the toliability ~~raise~~method ~~capital~~of ~~necessary~~accounting tofor ~~sustain~~income ~~our~~taxes. ~~anticipated~~Deferred ~~operations~~tax assets and ~~implement~~liabilities ~~our~~are ~~business~~recognized ~~plan,~~for ●the ~~Our~~future ~~ability~~tax consequences toattributable ~~implement our business plan, ● Our ability~~ to ~~generate~~financial ~~sufficient~~statements ~~cash~~carrying toamounts ~~pay~~of ~~our~~existing ~~lenders~~assets and ~~other~~liabilities ~~creditors,~~and ●their ~~Our~~respective ~~ability~~tax ~~to employ~~ bases and ~~retain~~operating ~~qualified~~loss ~~management~~ and ~~employees,~~tax ●credit ~~Our~~carryforwards. ~~dependence~~The onmeasurement ~~the efforts and abilities~~ of ~~our~~deferred ~~current~~tax ~~employees~~assets and ~~executive~~liabilities ~~officers,~~is ●based ~~Changes~~on inprovisions ~~government~~of ~~regulations that are~~ applicable tax tolaw. ~~our current or anticipated business, ● Changes in the demand for our services and different food trends, ●~~ The ~~degree~~measurement ~~and nature~~ of ~~our~~deferred ~~competition,~~tax ●assets ~~The~~is ~~lack~~reduced, ofif ~~diversification of our business plan~~necessary, ●by ~~The general volatility of the capital markets and the establishment of~~ a ~~market~~valuation ~~for~~allowance ~~our~~based ~~shares,~~on ~~and ● Disruption in~~ the ~~economic~~amount ~~and financial conditions primarily from the impact~~ of ~~past~~tax ~~terrorist attacks in the United States~~benefits that, ~~threats~~based ofon ~~future~~available ~~attacks~~evidence, ~~police~~is ~~and~~not ~~military~~expected ~~activities~~to ~~overseas~~be ~~and other disruptive worldwide political and economic events, health pandemics and environmental weather conditions~~realized.

We are also subject to other risks detailed from time to time in our other filings with the SEC and elsewhere in this report. Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.Background

We were incorporated in the State of Wyoming on October 17, 2016, under the name of Amazing Ventures, Inc. Our articles of incorporation were amended on February 12, 2018 to change our name to Rest EZ, Inc.

~~Table~~Rest EZ, ofInc. ~~Contents~~is in full production with product distribution to wholesalers and retailers as well as being available online at www.RestEz.net. Rest EZ Inc. has one sleep liquid gel capsule (named Rest EZ Sleep Aid Supplement).

~~Critical Accounting Policy and Estimates~~General Introduction

~~Use~~Rest EZ, Inc. is currently in full production with full product distribution to wholesalers and retailers as well as online at www.RestEz.net. Rest EZ Inc. has commenced its major operations of ~~Estimates~~having one product, a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider (Sport Energy) that manufactures liquid gels to various companies, but has not distributed this product to anyone except Rest EZ, Inc. The Company is presently marketing the Rest EZ Sleep Aid Supplement to wholesalers, retailers, and online at www.RestEz.net. Rest EZ, Inc. is considered a Full Production and Full Distribution stage company because it has commenced all major operations with outside wholesalers and retailers, and has sold 77,694 bottles for $664,943 in total sales. The Company did not have any sales during the ~~Preparation~~quarter ended June 30, 2024 and had an accumulated deficit of ~~Financial~~$317,937 ~~Statements~~as of June 30, 2024.

The product ~~preparation~~is ofa ~~these~~liquid ~~financial~~gel ~~statements~~capsule ~~requires~~containing ussoybean ~~to make estimates and judgments that affect the reported amounts of assets~~oil, ~~liabilities~~gelatin, ~~revenues~~valerian ~~and expenses~~root, ~~and~~rosehips ~~related~~extract, ~~disclosure~~purified ofwater, ~~contingent~~yellow ~~assets and liabilities. These estimates include certain assumptions related to doubtful accounts receivable~~beeswax, ~~stock~~L-~~based services~~Theanine, ~~valuation of financial instruments~~ L-Threonine, ~~operating right of use assets and liabilities~~lecithin, ~~and income taxes~~St. OnJohn’s anWort ~~on-going basis~~extract, welemon ~~evaluate~~balm ~~these~~leaf ~~estimates~~extract, ~~including~~niacin ~~those related to revenue recognition~~ and ~~concentration of credit risk~~melatonin. WeThe ~~base~~product ~~our~~is ~~estimates on historical experience and on various other assumptions that are believed~~ to be ~~reasonable~~taken ~~under~~orally, preferably ~~the~~with ~~circumstances~~water, ~~the~~at ~~results~~bedtime. ofUpon ~~which~~digestion ~~form~~ the ~~basis~~product ~~for~~is ~~making~~absorbed ~~judgments~~within ~~about~~ the ~~carrying~~bloodstream ~~values~~ultimately ofproviding ~~assets~~the ~~and~~user ~~liabilities~~an ~~that~~enhanced ability ~~are not readily apparent from other sources. Accounts subject~~ to ~~estimate and judgements are accounts receivable reserves, income taxes, intangible assets, contingent liabilities, and equity-based instruments~~sleep. ~~Actual~~One ~~results~~serving ~~may~~is ~~differ~~two ~~from~~capsules ~~these~~per ~~estimates under different assumptions or conditions~~day. WeIntended ~~believe~~customers ~~our~~are ~~estimates~~adults ~~have~~(persons ~~not~~over ~~been~~18 ~~materially inaccurate in past~~ years, ~~and~~of ~~our~~age) ~~assumptions~~who ~~are~~experience ~~not~~difficulty with ~~likely to change in the foreseeable future~~sleeping.

~~Fair Value of Financial Instruments~~12

~~The~~Table ~~Company measures its financial assets and liabilities in accordance with accounting principles generally accepted in the United States~~ of America. The estimated fair values approximate their carrying value because of the short-term maturity of these instruments or the stated interest rates are indicative of market interest rates. These fair values have historically varied due to the market price of the Company’s stock at the date of valuation.Contents

~~Income~~Beyond the ~~Taxes~~general FDA requirement that every dietary supplement be labeled as such, either with the term “dietary supplement” or with a term that substitutes a description of the product’s dietary ingredient(s) for the word “dietary” (e.g., “herbal supplement” or “calcium supplement”), and the FDA’s safety monitoring responsibilities for dietary supplement firms once a dietary supplement is on the market, there are no additional FDA requirements specific to this product, and federal law does not require dietary supplements to be proven safe to FDA’s satisfaction before they are marketed. Rest EZ, Inc. has not sent the product to the FDA for approval because it is not required, and because it would be a lengthy and costly process to have this product FDA approved when not required.

The liquid ~~Company~~gel ~~uses~~capsules ~~the~~are ~~liability~~manufactured ~~method~~by ofSport ~~accounting~~Energy, ~~for~~who ~~income~~adheres ~~taxes.~~to ~~Deferred~~very ~~tax~~strict ~~assets~~guidelines ~~and~~placed ~~liabilities~~upon ~~are~~them ~~recognized~~by ~~for~~all ~~the~~agencies ~~future~~with ~~tax~~whom they ~~consequences~~work. ~~attributable~~Sport toEnergy ~~financial~~indicated ~~statements~~they ~~carrying~~may ~~amounts~~use ofother ~~existing~~outside ~~assets~~sources ~~and~~to ~~liabilities~~produce ~~and~~our ~~their~~product ~~respective~~but ~~tax~~has ~~bases~~verbally ~~and~~indicated ~~operating~~that ~~loss~~all ~~and~~their ingredients ~~tax~~used ~~credit~~in ~~carryforwards.~~any ~~The~~consumable ~~measurement~~products ofare ~~deferred~~very ~~tax~~closely ~~assets~~monitored. ~~and~~The ~~liabilities~~manufacturer is ~~based~~registered onas ~~provisions~~a ofGood ~~applicable~~Manufacturing ~~tax~~Practices (GMP) ~~law.~~company ~~The~~with ~~measurement~~NSF’s ofDietary ~~deferred~~Supplement ~~tax~~Certification ~~assets~~program isand ~~reduced,~~the ifNatural ~~necessary,~~Products byAssociation (NPA), a ~~valuation~~status ~~allowance~~they ~~based~~have held onfor ~~the~~many ~~amount~~years. Manufacturing of ~~tax~~the ~~benefits~~capsules ~~that~~is complete, ~~based~~although onmanufacturing ~~available~~of ~~evidence,~~the iscapsules ~~not~~will ~~expected~~be toongoing beas ~~realized~~supply and demand dictates.

~~Background~~Rest EZ, Inc. has nothing proprietary about their product. At this time, Rest EZ, Inc. has no intellectual properties in connection with the capsules. However, we believe our product is superior to that of the competition due to the product being in a soft gel form, avoiding substantial product break down before digestion as happens with many competitors’ products.

WeThe competition ~~were~~for ~~incorporated~~and difficulty in ~~the~~selling ~~State~~a ofsleeping ~~Wyoming~~aid onsupplement ~~October~~product ~~17,~~may ~~2016,~~affect ~~under~~our ~~the~~ability ~~name~~to ofmaintain ~~Amazing~~profitable ~~Ventures,~~operations in ~~Inc~~the future. ~~Our~~Companies ~~articles~~that ofare ~~incorporation~~engaged ~~were~~in ~~amended~~this onproduct ~~February~~market 12include large, ~~2018~~established tocompanies ~~change~~with ~~our~~substantial ~~name~~capabilities toand long ~~Rest~~earnings ~~EZ, Inc~~records.

OnThe Company ~~September~~has ~~26,~~minimal ~~2023~~revenue. Without additional capital, the Company will not be able to remain in business. These factors raise a substantial doubt about the Company’s ~~board~~ability ofto ~~directors~~continue ~~approved~~as a ~~reverse~~going ~~stock~~concern. ~~split~~Company infinancial statements do not include any adjustments to reflect the ~~ration~~possible future effects on the recoverability and classification of 1assets ~~for~~or ~~1000~~the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. ~~There~~Achievement ~~were~~of 20Rest EZ,~~000~~ Inc.’s business objective is basically dependent upon the judgment,~~000~~ ~~shares~~skill ofand knowledge the Company’s ~~common~~management. ~~stock~~Mr. ~~outstanding~~Sosa ~~immediately~~is ~~before~~currently the ~~reverse~~Company’s sole ~~stock~~executive ~~split,~~officer and ~~20,000~~director. ~~shares~~There ofcan ~~common~~be ~~stock~~no ~~outstanding~~assurance ~~immediately~~that ~~after~~a ~~the~~suitable ~~reverse~~replacement ~~stock~~could ~~split,~~be afound ~~decrease~~for ofour 19sole executive officer and director upon his retirement,~~980~~ resignation,~~000~~ ~~shares.~~inability ~~The~~to ~~Company~~act ~~issued~~on 33our ~~shares~~behalf, ofor ~~common~~death. ~~stock~~Should ~~due~~the toCompany ~~rounding~~be ~~pursuant~~unable to ~~the~~raise ~~reverse~~additional financing ~~stock~~it ~~split~~would be unable to remain in business.

~~Rest~~Business Development EZ, Inc. is in full production with product distribution to wholesalers and retailers as well as being available online at www.RestEz.net. Rest EZ Inc. has one sleep liquid gel capsule (named Rest EZ Sleep Aid Supplement).

~~General~~The Company ~~Introduction~~was incorporated on October 17, 2016. The Company has passed through all stages of development to full operations from incorporation, and the Company is currently in full production and distribution to wholesalers and retailers as well as online at www.RestEz.net.

~~Rest~~Initial Sales EZ, Inc. is currently in full production with full product distribution to wholesalers and retailers as well as online at www.RestEz.net. Rest EZ Inc. has commenced its major operations of having one product, a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider (Sport Energy) that manufactures liquid gels to various companies, but has not distributed this product to anyone except Rest EZ, Inc. The Company is presently marketing the Rest EZ Sleep Aid Supplement to wholesalers, retailers, and online at www.RestEz.net. Rest EZ, Inc. is considered a Full Production and Full Distribution stage company because it has commenced all major operations with outside wholesalers and retailers, and has sold 77,694 bottles for $664,943 in total sales. The Company did not have any sales during the quarter ended December 31, 2023 and had an accumulated deficit of $335,676 as of December 31, 2023.Strategy

~~The~~We have ~~product~~established is a ~~liquid~~very ~~gel~~strong ~~capsule~~sales ~~containing~~approach; ~~soybean~~our ~~oil,~~approach ~~gelatin,~~utilizes ~~valerian~~direct ~~root,~~sales ~~rosehips~~through ~~extract,~~Mr. ~~purified~~Sosa ~~water,~~to ~~yellow~~our ~~beeswax,~~wholesalers ~~L-Theanine,~~and ~~L-Threonine,~~retailers ~~lecithin,~~as well ~~St.~~as ~~John~~our company’s ~~Wort~~professional ~~extract,~~and ~~lemon~~easy ~~balm~~to ~~leaf~~use ~~extract,~~web ~~niacin~~site. ~~and~~Our ~~melatonin~~direct sales will be conducted by Mr. ~~The~~Sosa. ~~product~~He iswill tomarket bethe product ~~taken~~to ~~orally~~wholesalers nationally, ~~preferably~~to ~~with~~retail ~~water,~~chain atstores ~~bedtime~~and worldwide distributors. ~~Upon~~The ~~digestion~~Company’s ~~the~~current ~~product~~marketing isstrategy consists ~~absorbed~~of ~~within~~various ~~the~~Point ~~bloodstream~~of ~~ultimately~~Sale ~~providing~~materials to include advertising posters, flyers and magnetic strips with the ~~user~~Company’s anname and ~~enhanced~~its ~~ability~~product todeveloped ~~sleep~~by Mr. ~~One~~Sosa ~~serving~~in isthe ~~two~~past ~~capsules~~several ~~per day~~months. ~~Intended~~In ~~customers~~addition, ~~are~~sales ~~adults~~will ~~(persons~~be ~~over~~done 18with ~~years~~referrals, ofdistribution ~~age)~~by ~~who~~our wholesalers ~~experience~~and ~~difficulty~~online ~~with~~marketing ~~sleeping~~at www.RestEz.net.

13Description of Property

~~Table~~The Company uses a corporate office located at: 1398 W. Mason Hollow Drive, Riverton, Utah 84065. This facility is being provided to the Company free of ~~Contents~~charge by Mr. Sosa. Mr. Sosa is providing his own facility free of charge until the company needs additional space to store inventory exceeding 100,000 bottles. Mr. Sosa indicates he has enough room to store 100,000 bottles of Rest EZ product, so no additional room is needed at this time, or in the near future. There are currently no proposed programs for renovations, improvements or developments of the facility currently in use.

~~Beyond the general FDA requirement that every dietary supplement be labeled as such, either with the term "dietary supplement" or with a term that substitutes a description~~ Results of the product's dietary ingredient(s) for the word "dietary" (e.g., "herbal supplement" or "calcium supplement"), and the FDA’s safety monitoring responsibilities for dietary supplement firms once a dietary supplement is on the market, there are no additional FDA requirements specific to this product, and federal law does not require dietary supplements to be proven safe to FDA's satisfaction before they are marketed. Rest EZ, Inc. has not sent the product to the FDA for approval because it is not required, and because it would be a lengthy and costly process to have this product FDA approved when not required.Operations

~~The~~For the ~~liquid~~three ~~gel~~months ~~capsules~~ended ~~are~~June ~~manufactured~~30, by2024 ~~Sport~~and ~~Energy~~2023, ~~who~~the ~~adheres~~Company tohad ~~very~~gross ~~strict~~profit ~~guidelines~~of ~~placed upon them by all agencies with whom they work~~$0. ~~Sport~~General ~~Energy~~and ~~indicated~~administrative ~~they~~expenses ~~may~~were ~~use~~$33 ~~other~~and ~~outside~~$3,710 for ~~sources~~the tothree ~~produce~~months ~~our~~ended ~~product~~June ~~but~~30, ~~has~~2024 ~~verbally~~and ~~indicated~~2023, ~~that~~respectively. ~~all~~Interest ~~their~~expense, ~~ingredients~~which ~~used~~consisted inof ~~any~~imputed ~~consumable~~interest ~~products~~on ~~are~~related ~~very~~party loans, ~~closely~~was ~~monitored.~~$0 ~~The~~and ~~manufacturer~~$2,074 isfor ~~registered~~the asthree amonths ~~Good~~ended ~~Manufacturing~~June ~~Practices~~30, ~~(GMP)~~2024 ~~company~~and ~~with~~2023, ~~NSF’s~~respectively. ~~Dietary~~This ~~Supplement~~resulted ~~Certification~~in ~~program and~~ the ~~Natural~~Company ~~Products~~generating ~~Association (NPA),~~ a ~~status~~net loss ~~they have held for many years. Manufacturing~~ of ~~the~~$33 ~~capsules~~and ~~is complete~~$5,784 ~~although~~during ~~manufacturing of~~ the ~~capsules~~three ~~will~~months beended ~~ongoing~~June as30, ~~supply~~2024 and ~~demand~~2023, ~~dictates~~respectively.

Rest EZ, Inc. has nothing proprietary about their product. At this time, Rest EZ, Inc. has no intellectual properties in connection with the capsules. However, we believe our product is superior to that of the competition due to the product being in a soft gel form, avoiding substantial product break down before digestion as happens with many competitors’ products.13

~~The~~Table ~~competition~~of for and difficulty in selling a sleeping aid supplement product may affect our ability to maintain profitable operations in the future. Companies that are engaged in this product market include large, established companies with substantial capabilities and long earnings records.Contents

The Company has minimal revenue. Without additional capital, the Company will not be able to remain in business. These factors raise a substantial doubt about the Company’s ability to continue as a going concern. Company financial statements do not include any adjustments to reflect the possible future effects on the recoverability Liquidity and ~~classification~~Capital of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. Achievement of Rest EZ, Inc.’s business objective is basically dependent upon the judgment, skill and knowledge the Company’s management. Mr. Sosa is currently the Company’s sole executive officer and director. There can be no assurance that a suitable replacement could be found for our sole executive officer and director upon his retirement, resignation, inability to act on our behalf, or death. Should the Company be unable to raise additional financing it would be unable to remain in business.Resources

~~Business~~For the ~~Development~~three months ended June 30, 2024, cash used in operating activities was $0, consisting of our net loss of $33, interest on related party debt of $0 and a increase in accounts payable of $33; compared to $78 consisting of net loss of $5,784 and imputed interest on related party debt of $2,074 for the three months ended June 30, 2023. For the three months ended June 30, 2024 and 2023, cash provided by financing activities was $0 and $2,074, respectively, consisting of proceeds from related party debt for operating expenses.

~~The Company was incorporated on October 17, 2016. The Company has passed through all stages~~ Plan of ~~development to full operations from incorporation, and the Company is currently in full production and distribution to wholesalers and retailers as well as online at www.RestEz.net.~~Operation

~~Initial~~We have ~~Sales~~established ~~Strategy~~a very strong sales approach; our approach utilizes direct sales through Mr. Sosa to our wholesalers and retailers as well as our company’s professional and easy to use web site. Our direct sales will be conducted by Mr. Sosa. He will market the product to wholesalers nationally, to retail chain stores and worldwide distributors. The Company’s current marketing strategy consists of various Point of Sale materials to include advertising posters, flyers and magnetic strips with the Company’s name and its product developed by Mr. Sosa. In addition, sales will be done with referrals, distribution by our wholesalers, and online marketing at www.restez.net.

WeOver the ~~have~~next ~~established~~twelve amonths, ~~very~~Rest ~~strong~~EZ, ~~sales approach; our approach utilizes direct sales through Mr~~Inc. ~~Sosa~~plans to ~~our~~build ~~wholesalers~~out ~~and~~its ~~retailers~~reputation asfurther, ~~well as our company’s professional~~ and ~~easy~~expand to ~~use~~additional ~~web site. Our direct sales will be conducted by Mr. Sosa. He will market the product to~~ wholesalers ~~nationally~~, to retail chain stores, as ~~and~~well ~~worldwide~~as ~~distributors.~~expand ~~The~~sales ~~Company’s current marketing strategy consists of various Point of Sale materials~~ to ~~include advertising posters, flyers and magnetic strips with~~ the ~~Company’s name and its product developed by Mr~~public. ~~Sosa in the past several months. In addition, sales will be executed with referrals, distribution by our wholesalers and online marketing at www.RestEz.net.~~

~~Description~~Off-Balance Sheet ~~of Property~~Arrangements

~~The~~We have ~~Company~~no ~~uses~~off-balance asheet ~~corporate~~arrangements ~~office~~that ~~located~~have ~~at:~~or ~~1398~~are W.reasonably ~~Mason~~likely ~~Hollow Drive, Riverton, Utah 84065. This facility is being provided~~ to ~~the~~have ~~Company~~a ~~free~~current ofor ~~charge~~future byeffect ~~Mr.~~on ~~Sosa.~~our ~~Mr.~~financial ~~Sosa~~condition, changes isin ~~providing~~financial ~~his~~condition, ~~own facility free of charge until the company needs additional space to store inventory exceeding 100~~revenues,~~000~~ ~~bottles.~~or ~~Mr. Sosa indicates he has enough room to store 100~~expenses,~~000~~ ~~bottles~~results of ~~Rest EZ product~~operations, ~~so no additional room is needed at this time~~liquidity, orcapital inexpenditures ~~the near future. There are currently no proposed programs for renovations, improvements~~ or ~~developments~~capital ofresources ~~the~~that is ~~facility~~material ~~currently~~to ~~in use~~investors.

14Inflation

~~Table~~In the opinion of ~~Contents~~management, inflation has not had a material effect on the Company’s financial condition or results of operations.

~~Results~~Going Concern ~~of Operations~~Considerations

~~For~~The accompanying ~~the~~financial ~~three~~states ~~and~~have ~~nine~~been ~~months~~prepared ~~ended~~assuming ~~December~~that ~~31, 2023,~~ the Company ~~had~~will ~~gross~~continue ~~profit~~as ofa $0going concern. ~~General~~As ~~and~~discussed ~~administrative~~in ~~expenses~~Note ~~were~~3 ~~$1,020~~to the ~~and~~financial ~~$17~~statements,~~691~~ ~~for~~ the ~~three~~Company ~~and~~suffered ~~nine~~a ~~months~~net ~~ended~~loss ~~December~~from ~~31,~~operations ~~2023,~~and ~~respectively.~~has ~~Interest~~a ~~expense~~net capital deficiency, which ~~consisted~~raises ofsubstantial doubt ~~imputed~~about ~~interest~~its onability ~~related~~to ~~party~~continue ~~loans,~~as ~~was~~a ~~$164~~going ~~and~~concern. ~~$5,832~~Management’s ~~for~~plans ~~the~~regarding ~~three~~those ~~and~~matters ~~nine~~are ~~months~~also ~~ended~~described ~~December~~in ~~31,~~Note ~~2023, respectively~~3. The ~~This~~financial ~~resulted~~statements indo ~~the~~not ~~Company~~include ~~generating~~any aadjustments ~~net~~that ~~loss~~might ofresult ~~$1,184~~from ~~and $23,523 during~~ the ~~three~~outcome ~~and~~of ~~nine~~this ~~months ended December 31, 2023, respectively~~uncertainty.

~~For~~Risk Factors the three and nine months ended December 31, 2022, the Company had gross profit of $0. General and administrative expenses were $2,061 and $11,179 for the three and nine months ended December 31, 2022, respectively. Interest expense, which consisted of imputed interest on related party loans, was $2,586 and $7,671 for the three and nine months ended December 31, 2022, respectively. This resulted in the Company generating a net loss of $4,647 and $18,850 during the three and nine months ended December 31, 2022, respectively.

~~Liquidity~~The Company’s business and ~~Capital~~success ~~Resources~~is subject to numerous risk factors as detailed in its Form S-1/A and other of its Current Reports on Form 8-K all of which reports are available at no cost at www.sec.gov.

For the nine months ended December 31, 2023, cash used in operating activities was $17,357, consisting of our net loss of $23,523, interest on related party debt of $5,832, and an increase in accounts payable of $334; compared to cash used in operating activities of $11,083 consisting of net loss of $18,850, imputed interest on related party debt of $7,671, and an increase in accounts payable of $96 for the nine months ended December 31, 2022ITEM 4. ~~For~~CONTROLS ~~the~~AND ~~nine months ended December 31, 2023 and 2022, cash provided by financing activities was $17,313 and $10,829, respectively, consisting of proceeds from related party debt for operating expenses.~~PROCEDURES

~~Plan~~As of June 30, 2024 (the “Evaluation Date”), the Company’s management evaluated, with participation of ~~Operation~~its principal executive officer, the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on that evaluation, the Company’s principal executive officer concluded that the Company’s disclosure controls and procedures were ineffective as of June 30, 2024.

WeManagement assessed ~~have~~the ~~established~~effectiveness aof ~~very~~its ~~strong~~internal ~~sales~~control ~~approach;~~over ~~our~~financial ~~approach~~reporting ~~utilizes~~as ~~direct~~of ~~sales~~the ~~through~~Evaluation ~~Mr.~~Date ~~Sosa~~based toon ~~our~~criteria ~~wholesalers~~for ~~and~~effective internal ~~retailers~~control asover ~~well~~financial asreporting ~~our~~described ~~company’s~~in ~~professional~~Internal ~~and~~Control—Integrated ~~easy~~Framework toissued ~~use~~in ~~web~~2013 ~~site.~~by ~~Our~~the ~~direct~~Committee ~~sales~~of Sponsoring ~~will~~Organizations beof ~~conducted~~the byTreadway MrCommission. ~~Sosa.~~The Hematerial ~~will~~weaknesses ~~market~~identified ~~the~~during ~~product~~management’s toassessment ~~wholesalers~~were ~~nationally,~~(i) a tolack ~~retail~~of ~~chain~~sufficient ~~stores~~internal ~~and~~accounting ~~worldwide~~resources; ~~distributors.~~(ii) ~~The~~a ~~Company’s~~lack ~~current~~of ~~marketing~~segregation ~~strategy~~of ~~consists~~duties to ensure adequate review of ~~various~~financial ~~Point~~statement preparation, (iii) lack of ~~Sale~~an ~~materials~~independent toboard ~~include~~of ~~advertising~~directors ~~posters,~~or ~~flyers~~audit committee, and ~~magnetic~~(iv) ~~strips~~lack ~~with~~of ~~the~~written ~~Company’s~~documentation ~~name~~of ~~and~~our ~~its~~internal control ~~product~~policies ~~developed~~and ~~by Mr~~procedures. ~~Sosa.~~ In ~~addition~~light of these material weaknesses, ~~sales~~management ~~will~~has beconcluded ~~accomplished~~that ~~through~~we ~~referrals,~~did ~~distribution~~not bymaintain ~~our~~effective ~~wholesalers,~~internal control ~~and~~over ~~online~~financial ~~marketing~~reporting at ~~www~~the Evaluation Date.~~restez.net.~~

~~Over the next twelve months, Rest EZ, Inc. plans to build out its reputation further, and expand to additional wholesalers, retail chain stores, as well as expand sales to the public.~~14

~~Off-Balance~~Table ~~Sheet~~of ~~Arrangements~~Contents

WePART II ~~have~~OTHER no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.INFORMATION

~~Inflation~~ITEM 1. Legal Proceedings

~~In the opinion of management, inflation has not had a material effect on the Company’s financial condition or results of operations~~None.

~~Going~~ITEM 2. ~~Concern~~Unregistered ~~Considerations~~Sales of Equity Securities and Use of Proceeds

~~The accompanying financial states have been prepared assuming that the Company will continue as a going concern~~None. As discussed in Note 3 to the financial statements, the Company suffered a net loss from operations and has a net capital deficiency, which raises substantial doubt about its ability to continue as a going concern. Management’s plans regarding those matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

~~Risk~~ITEM 3. ~~Factors~~Defaults Upon Senior Securities

~~The Company’s business and success is subject to numerous risk factors as detailed in its Form S-1/A and other of its Current Reports on Form 8-K all of which reports are available at no cost at www~~None.~~sec.gov.~~

15ITEM 4. Mine Safety Disclosures

~~Table of Contents~~Not applicable.

ITEM 4 5. ~~CONTROLS~~Other ~~AND PROCEDURES~~Information

As of December 31, 2023 (the “Evaluation Date”), the Company’s management evaluated, with participation of its principal executive officer, the effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)None. ~~Based on that evaluation, the Company’s principal executive officer concluded that the Company’s disclosure controls and procedures were ineffective as of December 31, 2023.~~

Management assessed the effectiveness of its internal control over financial reporting as of the Evaluation Date based on criteria for effective internal control over financial reporting described in Internal Control—Integrated Framework issued in 2013 by the Committee of Sponsoring Organizations of the Treadway CommissionITEM 6. The material weaknesses identified during management’s assessment were (i) a lack of sufficient internal accounting resources; (ii) a lack of segregation of duties to ensure adequate review of financial statement preparation, (iii) lack of an independent board of directors or audit committee, and (iv) lack of written documentation of our internal control policies and procedures. In light of these material weaknesses, management has concluded that we did not maintain effective internal control over financial reporting at the Evaluation Date.Exhibits

Exhibit No.		Description
3.1		Articles of Incorporation (1)
3.2		Amended Articles of Incorporation for Name Change to Rest EZ (1)
3.3		Amended Articles of Incorporation for Name Change to Rest EZ, Inc. (1)
3.4		Bylaws (1)
3.5		Amended Articles of Incorporation for Reverse Stock Split (2)
3.6*		Amended Articles of Incorporation for Issuance of Shares
31.1*		Section 302 Certification
31.2*		Section 302 Certification
32.1*		Section 906 Certification
32.2*		Section 906 Certification
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF*		Inline XBRL Taxonomy Extension Definitions Linkbase
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase
104*		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

~~Table~~* ofFiled ~~Contents~~herewith.

~~PART~~(1) IIPreviously ~~OTHER~~filed ~~INFORMATION~~with the Company’s Form S-1 filed with the Securities and Exchange Commission on May 26, 2021.

~~ITEM~~(2) 1.Previously ~~Legal~~filed ~~Proceedings~~with the Company’s Form 10-Q for the period ended September 30, 2023, filed with the Securities and Exchange Commission on January 16, 2024.

~~None.~~15

~~ITEM~~Table ~~2. Unregistered Sales~~ of ~~Equity Securities and Use of Proceeds~~Contents

~~None.~~SIGNATURES

~~ITEM~~Pursuant to 3.the ~~Defaults~~requirements ~~Upon~~of ~~Senior~~the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

None.

	Rest EZ, Inc.

Date: April 25, 2025	By: /s/ Brandon Sosa
	Brandon Sosa
	President, Chief Executive Officer (Principal Executive Officer)

ITEM 4. Mine Safety Disclosures

Date: April 25, 2025	By: /s/ Brandon Sosa
	Brandon Sosa
	Chief Financial Officer (Principal Financial and Accounting Officer)

~~Not applicable.~~16

~~ITEM 5. Other Information~~ NONE 0001733861 false 2025 Q1 --03-31 0001733861 2024-04-01 2024-06-30 0001733861 2024-06-30 0001733861 2024-03-31 0001733861 us-gaap:RelatedPartyMember 2024-06-30 0001733861 us-gaap:RelatedPartyMember 2024-03-31 0001733861 2023-04-01 2023-06-30 0001733861 us-gaap:CommonStockMember 2023-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001733861 us-gaap:RetainedEarningsMember 2023-03-31 0001733861 2023-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001733861 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001733861 us-gaap:CommonStockMember 2023-06-30 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001733861 us-gaap:RetainedEarningsMember 2023-06-30 0001733861 2023-06-30 0001733861 us-gaap:CommonStockMember 2024-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001733861 us-gaap:RetainedEarningsMember 2024-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001733861 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001733861 us-gaap:CommonStockMember 2024-06-30 0001733861 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001733861 us-gaap:RetainedEarningsMember 2024-06-30 0001733861 srt:ChiefExecutiveOfficerMember 2024-06-30 0001733861 srt:ChiefExecutiveOfficerMember 2024-03-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares

None.

ITEM 6. Exhibits

Exhibit No.		Description
3.1*		Articles of Incorporation
3.2*		Amended Articles of Incorporation for Name Change to Rest EZ
3.3*		Amended Articles of Incorporation for Name Change to Rest EZ, Inc.
3.4**		Amended Articles of Incorporation for Reverse Stock Split
3.5*		Bylaws
31.1		Section 302 Certification
31.2		Section 302 Certification
32.1		Section 906 Certification
32.2		Section 906 Certification
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF		Inline XBRL Taxonomy Extension Definitions Linkbase
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Previously filed with the Company's Form S-1, filed with the Securities and Exchange Commission on May 26, 2021.

** Previously filed with the Company’s Form 10-Q for the period ended September 30, 2023, filed with the Securities and Exchange Commission on January 16, 2024.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Rest EZ, Inc.
Date: March 5, 2024	By: /s/ Brandon Sosa
	Brandon Sosa
	President, Chief Executive Officer (Principal Executive Officer)

Date: March 5, 2024	By: /s/ Brandon Sosa
	Brandon Sosa
	Chief Financial Officer (Principal Financial and Accounting Officer)

NONE false --03-31 Q3 2024 0001733861 0001733861 2023-04-01 2023-12-31 0001733861 2024-02-20 0001733861 2023-12-31 0001733861 2023-03-31 0001733861 us-gaap:RelatedPartyMember 2023-12-31 0001733861 us-gaap:RelatedPartyMember 2023-03-31 0001733861 2023-10-01 2023-12-31 0001733861 2022-10-01 2022-12-31 0001733861 2022-04-01 2022-12-31 0001733861 us-gaap:CommonStockMember 2022-09-30 0001733861 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001733861 us-gaap:RetainedEarningsMember 2022-09-30 0001733861 2022-09-30 0001733861 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001733861 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001733861 us-gaap:CommonStockMember 2022-12-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001733861 us-gaap:RetainedEarningsMember 2022-12-31 0001733861 2022-12-31 0001733861 us-gaap:CommonStockMember 2023-09-30 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001733861 us-gaap:RetainedEarningsMember 2023-09-30 0001733861 2023-09-30 0001733861 us-gaap:CommonStockMember 2023-10-01 2023-12-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-10-01 2023-12-31 0001733861 us-gaap:RetainedEarningsMember 2023-10-01 2023-12-31 0001733861 us-gaap:CommonStockMember 2023-12-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001733861 us-gaap:RetainedEarningsMember 2023-12-31 0001733861 us-gaap:CommonStockMember 2022-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001733861 us-gaap:RetainedEarningsMember 2022-03-31 0001733861 2022-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-12-31 0001733861 us-gaap:RetainedEarningsMember 2022-04-01 2022-12-31 0001733861 us-gaap:CommonStockMember 2023-03-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001733861 us-gaap:RetainedEarningsMember 2023-03-31 0001733861 us-gaap:CommonStockMember 2023-04-01 2023-12-31 0001733861 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-12-31 0001733861 us-gaap:RetainedEarningsMember 2023-04-01 2023-12-31 0001733861 2023-09-25 0001733861 2023-09-26 0001733861 srt:ChiefExecutiveOfficerMember 2023-03-31 0001733861 2023-12-22 2023-12-22 0001733861 2023-12-22 0001733861 2023-09-26 2023-09-26 0001733861 srt:ChiefExecutiveOfficerMember 2023-04-01 2023-12-31 0001733861 us-gaap:InvestorMember 2023-04-01 2023-12-31 0001733861 us-gaap:SubsequentEventMember 2024-01-14 2024-01-14 0001733861 us-gaap:SubsequentEventMember 2024-01-14 0001733861 rest:January142024NotesMember us-gaap:SubsequentEventMember 2024-02-15 2024-02-15 0001733861 us-gaap:SubsequentEventMember 2024-02-09 2024-02-09 0001733861 us-gaap:SubsequentEventMember 2024-02-09 0001733861 rest:February92024NotesMember us-gaap:SubsequentEventMember 2024-02-15 2024-02-15 0001733861 us-gaap:SubsequentEventMember 2024-01-17 2024-01-17 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:USD compsci:item

Filing Compare · REST EZ Inc.